![Jennifer Buell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 756 426 $ in data 31/07/2026
Dr. Jennifer S.
Buell is a President, Chief Executive Officer & Director at MiNK Therapeutics, Inc., an Independent Director at Protagenic Therapeutics, Inc., a Chief Executive Officer at AgenTus Therapeutics Ltd. and a Chief Executive Officer at AgenTus Therapeutics SA. She is on the Board of Directors at Agenus, Inc., MiNK Therapeutics, Inc. and Protagenic Therapeutics, Inc. She received her graduate degree from Tufts University and a doctorate degree from Tufts University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 23/04/2026 | 57.942 ( 1,16% ) | 608 391 $ | 31/07/2026 | |
AGENUS INC. 0,04% | 05/08/2026 | 19.738 ( 0,04% ) | 148 035 $ | 31/07/2026 |
| 30/11/2025 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| PROTAGENIC THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 18/07/2020 |
| MINK THERAPEUTICS, INC. | Amministratore Delegato | 01/02/2021 |
| AGENUS INC. | Direttore/Membro del Consiglio | 11/06/2024 |
AgenTus Therapeutics SA | Amministratore Delegato | - |
AgenTus Therapeutics Ltd. | Amministratore Delegato | - |
| Società | Posizione | Fine |
|---|---|---|
| AGENUS INC. | Presidente | 31/12/2021 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
Agenus, Inc.
 Agenus, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of technologies to treat cancers and infectious diseases | Health Technology |
Tufts University
 Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protagenic Therapeutics, Inc.
 Protagenic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company that engages in discovery and development of therapeutics to treat stress-related neuropsychiatric & mood disorders | Health Technology |
MiNK Therapeutics, Inc.
 MiNK Therapeutics, Inc. BiotechnologyHealth Technology Provides bio pharmaceutical services | Health Technology |
AgenTus Therapeutics Ltd. | |
AgenTus Therapeutics SA |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
